Outcomes of MPN patients versus non-MPN patients hospitalized for COVID-19

Gabriela Hobbs, MD, Massachusetts General Hospital, Boston, MA, discusses some findings from a retrospective analysis which compared the outcome of myeloproliferative neoplasm (MPN) patients who were hospitalized for COVID-19 versus non-MPN patients who were hospitalized for COVID-19. Dr Hobbs explains that hospitalized patients with MPNs had a higher incidence of thrombotic events compared to non-MPN patients. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA, 2021.